Bio-Gate AG

Equities

BIG1

DE000BGAG981

Medical Equipment, Supplies & Distribution

Delayed Deutsche Boerse AG Other stock markets 11:20:01 2024-04-30 am EDT			5-day change	1st Jan Change
0.99 ^EUR	+1.02%		-1.00%	-6.60%

2023	Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants	CI

Bio-Gate AG acquired the remaining 30% stake in BioEpiderm GmbH.

April 19, 2016

Bio-Gate AG acquired the remaining 30% stake in BioEpiderm GmbH in stock on April 20, 2016. For the acquisition of shares, Bio-Gate AG issued a total of 0.21 million new shares.

Bio-Gate AG completed the acquisition of the remaining 30% stake in BioEpiderm GmbH on April 20, 2016.

Latest news about Bio-Gate AG

Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants	23-07-31	CI
Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-29	CI
Bio-Gate AG Auditor Raises 'Going Concern' Doubt	23-04-28	CI
Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-06	CI
Avicanna Inc. Completes Its First Commercial Export of Its Derma-Cosmetics Brand Pura H&WÃ– into the European Union	22-07-07	CI
Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-07	CI
Bio-Gate AG Auditor Raises 'Going Concern' Doubt	22-04-06	CI
Avicanna Expands its Derma-Cosmetics Brand Pura H&W into the European Union through a Partnership with Bio-Gate AG	22-04-05	CI
Bio-Gate Ag Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-06	CI
Bio-Gate AG announced that it expects to receive €2.505126 million in funding	21-01-20	CI
Bio-Gate AG Successfully Markets Antiviral and Antibacterial Protective Film Spray for Surfaces	20-10-28	CI
Bio-Gate AG announced that it expects to receive €0.500031 million in funding	20-05-11	CI
Bio-Gate AG announced that it expects to receive €1 million in funding	19-04-17	CI
Bio-Gate AG announced that it expects to receive €1.58 million in funding from Alto Invest	17-10-18	CI
Bio-Gate AG announced that it has received €0.69 million in funding	16-07-31	CI
Bio-Gate AG announced that it expects to receive €0.69 million in funding	16-07-27	CI
Bio-Gate AG acquired the remaining 30% stake in BioEpiderm GmbH.	16-04-19	CI
Bio-Gate AG Signs License Agreement with VetBiotek, Inc	15-02-05	CI
Bio-Gate AG announced that it has received €0.53 million in funding.	14-12-01	CI
Bio Gate AG Announces Earnings Results for 2013	14-04-04	CI
Bio-Gate AG announced that it has received €0.43 million in funding.	12-08-27	CI

Chart Bio-Gate AG

Duration

Period

More charts

Company Profile

Bio-Gate AG is a Germany-based medical technology company. The Company employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. It produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The Company incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BIO-GATE AG	-6.60%	9.78M
ABBOTT LABORATORIES	-3.72%	184B
MEDTRONIC PLC	-2.60%	107B
BECTON, DICKINSON AND COMPANY	-3.79%	67.78B
DEXCOM, INC.	+2.66%	50.66B
CENCORA, INC.	+16.39%	47.64B
HOYA CORPORATION	+4.60%	41.12B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.38%	26.3B
WEST PHARMACEUTICAL SERVICES, INC.	+1.52%	26.04B
ZIMMER BIOMET HOLDINGS, INC.	-1.17%	24.71B

Other Medical Equipment, Supplies & Distribution